307 related articles for article (PubMed ID: 18258559)
1. [Evidence-based optimal treatment strategy of patients with angina pectoris].
Jánosi A
Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
[TBL] [Abstract][Full Text] [Related]
2. [The evidence-based invasive therapy of stable angina pectoris].
Becker D; Merkely B
Orv Hetil; 2008 Feb; 149(7):299-304. PubMed ID: 18258560
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of stable angina pectoris. "Mother Courage and her children"].
Nagy V; Czuriga I
Orv Hetil; 2008 Feb; 149(7):291. PubMed ID: 18258558
[No Abstract] [Full Text] [Related]
4. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
5. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
[TBL] [Abstract][Full Text] [Related]
6. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
8. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
9. The place of metabolic agents in the management of stable angina pectoris.
Jackson G
Rev Port Cardiol; 1999 Sep; 18 Suppl 4():IV23-7. PubMed ID: 10555450
[TBL] [Abstract][Full Text] [Related]
10. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
[TBL] [Abstract][Full Text] [Related]
11. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
Simoons ML; Windecker S
Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis.
Muller O; Mangiacapra F; Ntalianis A; Verhamme KM; Trana C; Hamilos M; Bartunek J; Vanderheyden M; Wyffels E; Heyndrickx GR; van Rooij FJ; Witteman JC; Hofman A; Wijns W; Barbato E; De Bruyne B
JACC Cardiovasc Interv; 2011 Nov; 4(11):1175-82. PubMed ID: 22035875
[TBL] [Abstract][Full Text] [Related]
13. [The FAME 2 study].
Fineschi M; Marzilli M; Huqi A
G Ital Cardiol (Rome); 2013 Oct; 14(10):636-40. PubMed ID: 24121886
[No Abstract] [Full Text] [Related]
14. Keeping the patient in view: defining the appropriateness of percutaneous coronary interventions.
Curtis JP; Krumholz HM
Circulation; 2004 Dec; 110(25):3746-8. PubMed ID: 15611387
[No Abstract] [Full Text] [Related]
15. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
17. Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelines.
Cannon CP; Waheed S
Rev Cardiovasc Med; 2009; 10 Suppl 1():S21-9. PubMed ID: 19898284
[TBL] [Abstract][Full Text] [Related]
18. Alternative strategies for the management of chronic stable angina.
O'Rourke RA
Curr Probl Cardiol; 2010 Aug; 35(8):384-446. PubMed ID: 20620570
[TBL] [Abstract][Full Text] [Related]
19. Optimal medical therapy is a proven option for chronic stable angina.
O'Rourke RA
J Am Coll Cardiol; 2008 Sep; 52(11):905-7. PubMed ID: 18772059
[TBL] [Abstract][Full Text] [Related]
20. Treatment of stable angina pectoris.
Palaniswamy C; Aronow WS
Am J Ther; 2011 Sep; 18(5):e138-52. PubMed ID: 20861717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
